Growth differentiation factor 15-an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts

American Heart Journal

Volumn 160, Issue 6, 2010, Pages 1105-1112

  Raedle Hurst, Tanja M ^a   Koenigstein, Karsten ^a   Gruenhage, Frank ^a   Raedle, Jochen ^a   Herrmann, Eva ^b   Abdul Khaliq, Hashim ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GROWTH DIFFERENTIATION FACTOR 15;

ADOLESCENT; ADULT; ARTICLE; BLOOD FLOW VELOCITY; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; ELASTOGRAPHY; FEMALE; FONTAN PROCEDURE; FUNCTIONAL ASSESSMENT; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GROUPS BY AGE; HEART EJECTION FRACTION; HEART SINGLE VENTRICLE; HEART VENTRICLE FUNCTION; HUMAN; LIVER BLOOD FLOW; LIVER FIBROSIS; MALE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VEIN BLOOD FLOW;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; GROWTH DIFFERENTIATION FACTOR 15; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HEPATIC VEINS; HUMANS; MALE; POSTOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 78650111041     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.033     Document Type: Article

References (24)

1. Hsiao E.C., Koniaris L.G., and Zimmers-Koniaris T. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury Mol Cell Biol 20 2000 3742 3751
2. Xu J., Kimball T.R., and Lorenz J.N. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
3. Kempf T., von Haehling S., and Peter T. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J Am Coll Cardiol 50 2007 1054 1060
4. Lankeit M., Kempf T., and Dellas C. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism Am J Respir Crit Care Med 177 2008 1018 1025
5. Larsson D.A., Meurling C.J., and Holmqvist F. The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation Int J Cardiol 114 2007 345 351
6. Man B.L., and Cheung Y.F. Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure Heart Vessels 22 2007 398 403
7. Ghaferi A.A., and Hutchins G.M. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma J Thorac Cardiovasc Surg 129 2005 1348 1352
8. Wyatt H.L., Heng M.K., and Meerbaum S. Cross-sectional echocardiography. II. Analysis of mathematic models for quantifying volume of the formalin-fixed left ventricle Circulation 61 1980 1119 1125 (Pubitemid 10116248)
9. Castera L., Vergniol J., and Foucher J. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
10. Foucher J., Chanteloup E., and Vergniol J. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Gut 55 2006 403 408
11. Hess G., Runkel S., and Zdunek D. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors Clin Chim Acta 360 2005 187 193
12. Kempf T., Horn-Wichmann R., and Brabant G. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay Clin Chem 53 2007 284 291
13. Mahle W.T., Coon P.D., and Wernovsky G. Quantitative echocardiographic assessment of the performance of the functionally single right ventricle after the Fontan operation Cardiol Young 11 2001 399 406
14. Cheung Y.F., Penny D.J., and Redington A.N. Serial assessment of left ventricular diastolic function after Fontan procedure Heart 83 2000 420 424
15. Williams R.V., Ritter S., and Tani L.Y. Quantitative assessment of ventricular function in children with single ventricles using the Doppler myocardial performance index Am J Cardiol 86 2000 1106 1110
16. Abdul-Khaliq H., Schmitt B., and Rentzsch A. Evaluation of abnormal myocardial wall motions in patients with univentricular heart by tissue Doppler echocardiography Z Kardiol 92 2003 319 325
17. Maisel A., Mueller C., and Adams K. Jr State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
18. Ohuchi H., Takasugi H., and Ohashi H. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients Circulation 110 2004 2601 2608
19. Law Y.M., Ettedgui J., and Beerman L. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure Am J Cardiol 98 2006 520 524
20. Inoue S., Murakami Y., and Sano K. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation J Card Fail 6 2000 92 96
21. Albers S., Mir T.S., and Haddad M. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability Clin Chem Lab Med 44 2006 80 85
22. Mir T.S., Flato M., and Falkenberg J. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender Pediatr Cardiol 27 2006 73 77
23. Robbers-Visser D., Kapusta L., and van Osch-Gevers L. Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years J Thorac Cardiovasc Surg 138 2009 89 95
24. Friedrich-Rust M., Koch C., and Rentzsch A. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers J Thorac Cardiovasc Surg 135 2008 560 567